X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.biospace.com/article/releases/eleva-reaches-industrial-production-scale-and-prepares-for-clinical-development-of-factor-h/?s=71
https://www.fiercepharma.com/pharma/a-sanofi-evp-tipped-off-bioverativ-buy-now-doj-sec-are-after-4-7m-insider-trading
https://www.ema.europa.eu/documents/regulatory-procedural-guideline/list-centrally-authorised-products-requiring-notification-change-update-annexes_en-0.pdf
https://www.pharmacompass.com/pdf/news/advate-adynovate-antihemophilic-factor-nektar-therapeutics-v-bayer-1536041905.pdf
https://www.fiercepharma.com/pharma-shells-out-100b-m-a-2018-so-far-more-to-come-report
https://www.biospace.com/article/more-than-100-billion-spent-on-m-and-a-in-the-first-6-months-of-2018/
https://www.pharmacompass.com/pdf/news/adynovate-antihemophilic-factor-bayer-healthcare-llc-v-nektar-therapeutics-1521438358.pdf
https://www.shire.com/en/newsroom/2018/march/f98bkq?utm_content=corporate&utm_medium=sf183654567&utm_source=twitter&utm_campaign=corporate&sf183654567=1
https://www.pharmacompass.com/pdf/news/adynovateantihemophilic-bayer-healthcare-v-nektar-therapeutics-baxalta-1505212146.pdf
Market Place
Share 
